LCTC Lifeloc Technologies, Inc
Laboratory Analytical Instruments · OTC · SEC CIK 1493137 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY-49.9%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—
Margins
Gross margin42.7%
Operating margin-6.5%
Net margin-19.9%
FCF margin-3.8%
EBITDA margin-3.0%
Returns
ROE-40.5%
ROA-24.7%
ROIC (approx.)-9.9%
Asset turnover1.25x
Leverage & solvency
Liabilities / assets46.7%
Debt / equity0.27x
Current ratio3.95x
Interest coverage-4.24x
Cash quality & payout
Operating cash flow / net income-0.03x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue4.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $9.03M | $8.54M | $9.33M | $8.48M | $7.05M |
| Cost of revenue | $5.38M | $5.09M | $5.29M | $5.41M | $3.99M |
| Gross profit | $3.64M | $3.45M | $4.04M | $3.07M | $3.06M |
| R&D expense | $2.15M | $2.24M | $1.84M | $1.39M | $1.21M |
| SG&A expense | $1.39M | $1.25M | $1.17M | $1.22M | $1.11M |
| Operating income | -$1.23M | -$1.41M | -$191,135 | -$650,345 | -$268,913 |
| Interest expense | $119,190 | $40,145 | $41,566 | $43,081 | $51,272 |
| Pretax income | — | — | — | -$572,737 | $619,660 |
| Income tax | $1.16M | -$352,547 | -$368,253 | -$116,980 | -$56,307 |
| Net income | -$2.47M | -$1.05M | $205,614 | -$455,757 | $675,967 |
| EBITDA | -$786,566 | -$1.11M | $73,689 | -$17,927 | -$14,090 |
| EPS (basic) | -0.90 | -0.41 | 0.08 | -0.19 | 0.28 |
| EPS (diluted) | -0.90 | -0.41 | 0.08 | -0.19 | 0.27 |
| Weighted avg. shares (diluted) | 2.74M | 2.55M | 2.45M | 2.45M | 2.52M |
| Balance sheet | |||||
| Cash & equivalents | $746,001 | $1.24M | $1.77M | $2.35M | $2.57M |
| Receivables | $772,380 | $732,541 | $812,126 | $627,919 | $562,092 |
| Inventory | $2.63M | $3.00M | $3.02M | $2.73M | $2.67M |
| Current assets | $4.27M | $5.09M | $5.71M | $5.88M | $5.86M |
| PP&E, net | $2.30M | $2.38M | $2.00M | $2.25M | $2.59M |
| Intangibles | $71,039 | $78,723 | $64,439 | $69,679 | $134,428 |
| Total assets | $6.69M | $8.72M | $8.69M | $8.52M | $8.95M |
| Current liabilities | $836,870 | $743,575 | $1.15M | $1.14M | $1.08M |
| Short-term debt | — | $53,195 | $51,588 | $50,028 | $48,513 |
| Long-term debt | $1.06M | $1.12M | $1.17M | $1.22M | $1.27M |
| Total debt | $1.06M | $1.17M | $1.22M | $1.27M | $1.32M |
| Total liabilities | $2.58M | $2.50M | $2.33M | $2.36M | $2.36M |
| Shareholders' equity | $4.10M | $6.23M | $6.36M | $6.16M | $6.59M |
| Net debt | $312,425 | -$71,399 | -$544,790 | -$1.08M | -$1.26M |
| Shares outstanding | 2.75M | 2.66M | 2.45M | 2.45M | 2.45M |
| Cash flow statement | |||||
| Operating cash flow | -$499,319 | -$1.33M | -$525,740 | $54,325 | $182,943 |
| Capital expenditure | $462,793 | $539,731 | $6,811 | $213,206 | $265,867 |
| Free cash flow | -$962,112 | -$1.87M | -$532,551 | -$158,881 | -$82,924 |
| Investing cash flow | -$354,381 | -$689,446 | -$8,215 | -$222,576 | -$268,476 |
| Financing cash flow | $355,955 | $1.49M | -$52,178 | -$50,663 | $462,131 |
| Depreciation & amortization | $443,454 | $294,039 | $264,824 | $632,418 | $254,823 |
| Stock-based compensation | — | — | $0 | $17,202 | $17,157 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.